Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Clinical Trials

Cancer Research UK to test targeted drug in pancreatic cancer

A dual kinase inhibitor is entering a clinical trial for advanced pancreatic cancer in combination with gemcitabine.

Clearing up chemo options for frail and elderly patients with advanced oesophageal and stomach cancers

Older patients with advanced oesophageal and stomach cancers might benefit from low dose treatment, according to our unpublished clinical trial results.

Less chemotherapy better for older or frail patients with advanced stomach and oesophageal cancers

Less chemotherapy is as effective at controlling some advanced cancers for elderly patients, according to results of a Cancer Research UK funded trial.

Blood samples to help select the right early phase clinical trials for cancer patients

Scientists could help match cancer patients with no other treatment options to clinical trials with experimental medicines

Could the bacteria in our gut help treat cancer?

Gut bacteria may help some bowel cancers grow. Our Grand Challenge scientists want to see if tinkering with these tiny communities could be a new way to treat cancer.

Drug combination boosts kidney cancer survival in trials

Combining a targeted cancer drug with an immunotherapy extends the lives of advanced kidney cancer patients, according to two clinical trials.

A breath test with the goal of detecting multiple cancers is ready to start trials

The first clinical trial testing Owlstone’s Breath Biopsy® technology on a range of cancer types is now open.

Lung cancer screening part 1: the benefits and harms according to clinical trials

Researchers are trying to diagnose lung cancer early through screening, and studying if the benefits of early detection outweigh the harms.

Altering cancer metabolism helps treatments attack tumours

Restricting the ability of cancer cells to metabolise sugar could make oncolytic viruses more effective at attacking them.

Mirati Therapeutics joins Cancer Research UK’s Stratified Medicine Programme

Mirati Therapeutics, Inc. is the latest partner of Cancer Research UK’s Stratified Medicine Programme.

Pages